Cargando…
MON-513 Suppressing the Growth of Human Medullary Thyroid Cancer Cells Using FDA-Approved Drug
Medullary thyroid carcinoma (MTC) is a solid tumor of the parafollicular cells in the thyroid gland. MTC has worse prognosis, when compared with other differentiated thyroid cancers, and MTC patients with distant metastases have a low survival rate unless thyroidectomy is performed at an early stage...
Autores principales: | Ramachandran, Ilangovan, Ramadoss, Sivakumar, Nathan, Lauren, Kumaran, R Ileng, Chaudhuri, Gautam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207445/ http://dx.doi.org/10.1210/jendso/bvaa046.1639 |
Ejemplares similares
-
Inhibition of ALDH1A1 Activity in Cisplatin-Resistant Ovarian Cancer Cells Alters Their Cancer Stemness, Cell Cycle Profile and Mitochondrial Respiration Rate
por: Ramachandran, Ilangovan, et al.
Publicado: (2021) -
SAT-513 Thyroid Disease And Infrared Imaging Of Eyelids
por: Luu, Shannon, et al.
Publicado: (2020) -
MON-561 Medullary Thyroid Cancer in a Single Institution: Factors Associated With Biochemical Failure
por: Bettencourt-Silva, Rita, et al.
Publicado: (2019) -
MON-562 Retrospective Analysis of Medullary Thyroid Carcinoma: Comparison between Individuals with and without RET Germline Mutation
por: Costa, Cláudia, et al.
Publicado: (2019) -
MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019)